Pharmaceutical companies are coping with healthcare reform, patent expiration and skyrocketing R&D costs all while trying to improve the patient experience. In today’s healthcare landscape, how can companies drive their efforts “beyond the pill”?
Real-world evidence (RWE) can play a role in refining the overall patient experience, improving commercial operations and delivering better outcomes overall. However, RWE isn’t enough on its own to improve patient experience. Companies need a strong strategy in place to take advantage of it.
In this video, Aaron Mitchell, a principal in ZS’s Zurich office and leader of the global R&D practice, elaborates on the role that RWE can play in transforming the patient experience and shares some best practices for building and scaling a RWE strategy.